Evidence map›Paper›PMID 40978424›Full record

ArticleACS omega2025

Transport Mechanisms of 2D Nanoparticles across a Human Follicle-Associated Epithelium Model.

Sanoj Rejinold N, Ji-Yeong Kim, Geun-Woo Jin, Goeun Choi, Jin-Ho Choy

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sanoj Rejinold NIntelligent Nanohybrid Materials Laboratory (INML), Department of Chemistry, College of Science and Technology, Dankook University, Cheonan 31116, Republic of Korea.ORCID https://orcid.org/0000-0002-7045-0563
Ji-Yeong KimDepartment of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Republic of Korea.
Geun-Woo JinR&D Center, Hyundai Bioscience Co., Ltd., Seoul 07990, Republic of Korea.
Goeun ChoiIntelligent Nanohybrid Materials Laboratory (INML), Department of Chemistry, College of Science and Technology, Dankook University, Cheonan 31116, Republic of Korea.
Jin-Ho ChoyIntelligent Nanohybrid Materials Laboratory (INML), Department of Chemistry, College of Science and Technology, Dankook University, Cheonan 31116, Republic of Korea.ORCID https://orcid.org/0000-0002-4149-7100

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral drug delivery is the most common route for drug administration, because of its safety and convenience. Although there have been many drug delivery systems (DDS), inorganic clay-based nanosystems have been less explored. In particular, zinc basic salt (ZBS) has never been used as an oral DDS though it has high biocompatibility, anionic exchange capacity, and controlled release behavior. Here, we demonstrated the potency of ZBS as an oral DDS via an in vitro human follicle-associated epithelium (FAE) model to observe transport pathways for various-sized 2D ZBS (200 and 1000 nm) across the cellular monolayers. The decrease in transepithelial electrical resistance (TEER) for the Caco-2 and Raji B coculture monolayers incubated with 2D nanoparticles suggests that the paracellular tight junctions became loosened, confirming that the present layered nanoparticles were interacting with the epithelial cell layer and could open the tight junctions to improve drug uptake via transcellular and paracellular transport pathways also confirmed by the confocal images of the coculture cell monolayer. It is also found that the 200 nm-sized ZBS particles showed better translocation than the 1000 nm particles without any toxicity. Therefore, the 200 nm ZBS nanoparticles could be suggested as a promising oral drug delivery carrier.

Identifiers

PMID40978424
PMCPMC12444519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.